Prof. Dr. Sinan Akgöl is a prominent scientist whose academic career stands out for its interdisciplinary approach, integrating biochemistry, materials science, nanotechnology, biosensors, and artificial intelligence. Over a research trajectory spanning more than three decades, his work has evolved from molecular imprinting and functional polymers to AI-driven precision biosensing technologies. His research focuses on the intersection of intelligent molecular recognition, advanced biomaterials, and explainable AI (XAI) to develop innovative diagnostic platforms with real-world clinical and industrial applications.

His core research interests, which he actively pursues as the head of the Biorege Polymeric Nanosystems & AI-Assisted Applications Laboratory, include AI-driven precision biosensing, intelligent molecular recognition systems, molecularly imprinted polymer (MIP) technologies, electrochemical and optical biosensors, smart biomaterials and functional nanomaterials, point-of-care diagnostics, precision medicine, and translational nanobiotechnology.

Widely recognized on an international level for his scientific productivity and contributions to the literature, Prof. Dr. Akgöl has published 150+ SCI-indexed articles, received approximately 4,000 citations, and achieved an h-index of 36 throughout his career. Driven by a commitment to transforming scientific knowledge into innovation, he has developed 12 patented technologies and led numerous high-budget, competitive research projects. Dedicated to academic mentorship, he has supervised 11 PhD graduates, contributing significantly to training the next generation of scientists.

Prof. Dr. Sinan Akgöl’s core vision is based on the belief that the future of diagnostics lies not only in detecting biomarkers but in transforming them into intelligent systems capable of learning, adapting, and supporting clinical decision-making in real time. In line with this vision, he aims to build autonomous molecular sensing platforms that bridge laboratory discoveries with point-of-care applications, accelerating the transition toward personalized and digital healthcare. Believing that scientific discovery is most meaningful when it becomes technology, and technology improves human life, Akgöl actively pursues global collaborations with international universities, research institutes, healthcare organizations, and industry partners to develop disruptive projects at the interface of AI, molecular engineering, and translational diagnostics.

Assoc. Prof. Dr. Elif Ulutaş Deniz is currently working as an Associate Professor in the Department of Pharmacy Management at Atatürk University, Turkey. With over ten years of academic and professional experience, she specializes in pharmacy practice, pharmacy education, and communication in pharmacy. As a scholar in the field of social and administrative pharmacy, her research interests include community pharmacy practice, professional development in pharmacy, and the enhancement of pharmacy education.

Mosbah FERKHI is a Professor of Chemistry at the University Mohamed Seddik Benyahia of Jijel, Algeria. His research focuses on electrochemical analysis, electrocatalysis, and functional nanomaterials for energy and sensing applications. He specializes in solid oxide fuel cell materials, corrosion studies, and electrochemical impedance spectroscopy. He has authored numerous peer-reviewed publications on oxide-based nanostructures and electrochemical sensors for environmental and analytical applications.

Ade Arsianti was born in Mentok, Bangka, Indonesia on April 10, 1972. She is a lecturer and researcher at the Department of Medical Chemistry and the Drug Development Research Center (DDRC) – Indonesia Medical Education and Research Institute (IMERI), Faculty of Medicine University of Indonesia (FMUI). She can be reached via email at: arsi_ade2002@yahoo.com or ade.arsianti@ui.ac.id.

Ade Arsianti completed her Bachelor’s and Master’s degrees in Chemistry at the Faculty of Mathematics and Natural Sciences, University of Indonesia in 1995 and 1998, respectively. She earned her Doctor of Science degree from the Graduate School of Materials Science at Nara Institute of Science and Technology (NAIST), Japan, in 2011.

She has held several leadership positions, including Head of the Drug Development Research Center (DDRC) IMERI FMUI (2017–2026), Research Coordinator of the Medical Chemistry Department FMUI (2021–2025), Head of the Bioinformatics Specialization in Master Program of Biomedical Science FMUI (2021–2025), and Head of the Medical Chemistry Department FMUI (2013–2021). Additionally, she serves as Head of the Ecotoxicology and Xenobiotic Module for the undergraduate program in FMUI (2018–2025).

Her research focuses on Medicinal Chemistry, Synthetic Organic Chemistry, and Natural Product Chemistry. Ade Arsianti has published numerous scientific papers in international journals between 2022 and 2025, highlighting her contributions to the study of natural products, antioxidant activity, and anticancer compounds. Through her dedication to research and education, Ade Arsianti continues to contribute significantly to the advancement of medicinal chemistry and drug discovery in Indonesia and beyond.